Mass screening vs lockdown vs combination of both to control COVID-19: a systematic review

Abstract

Coronavirus disease 2019 (COVID-19) is a global pandemic. Non-pharmacological interventions, such as lockdown and mass testing, remain as the mainstay of control measures for the outbreak. We aim to evaluate the effectiveness of mass testing, lockdown, or a combination of both to control COVID-19 pandemic. A systematic search on 11 major databases was conducted on June 8, 2020. This review is registered in Prospero (CRD42020190546). We included primary studies written in English which investigate mass screening, lockdown, or a combination of both to control and/or mitigate the COVID-19 pandemic. There are four important outcomes as selected by WHO experts for their decision-making process: incident cases, onward transmission, mortality, and resource use. Among 623 studies, only 14 studies met our criteria. Four observational studies were rated as strong evidence and ten modelling studies were rated as moderate evidence. Based on one modelling study, mass testing reduced the total infected people compared to no mass testing. For lockdown, ten studies consistently showed that it successfully reduced the incidence, onward transmission, and mortality rate of COVID-19. A limited evidence showed that a combination of lockdown and mass screening resulted in a greater reduction of incidence and mortality rate compared to lockdown only. However, there is not enough evidence on the effectiveness of mass testing only.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report - 46. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed April 29, 2020.
2. Chen J. Pathogenicity and transmissibility of 2019-nCoV—a quick overview and 2 comparison with other emerging viruses. Microb and Infect. 2020 February; 22(2):69-71; doi:10.1016/j.micinf.2020.01.004.
3. Hou C, Chen J, Zhou Y, Hua L, Yuan J, He S, et al. The effectiveness of quarantine of Wuhan City against the Corona Virus Disease 2019 (COVID-19): a well-mixed SEIR model analysis. J Med Virol. 2020 April 25; doi:10.1002/jmv.25827.
4. Tang B, Xia F, Tang S, Bragazzi NL, Li Q, Sun X, et al. The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China. Int J Infect Dis. 2020 April 17; doi:10.1016/j.ijid.2020.03.018.
5. Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020 March 13; doi:10.1093/jtm/taaa039.
6. World Health Organization. (‎2020)‎. Coronavirus disease 2019 (‎COVID-19)‎: situation report, 37. World Health Organization. Available from: https://apps.who.int/iris/handle/10665/331224. Accessed April 29, 2020.
7. World Health Organization. (‎2020)‎. Coronavirus disease 2019 (‎COVID-19)‎: situation report, 57. World Health Organization. Available from: https://apps.who.int/iris/handle/10665/331481. Accessed April 29, 2020.
8. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097; doi:10.1371/journal.pmed.1000097.
9. Global surveillance for COVID-19 caused by human infection with COVID-19. WHO:virus. 2020 March 21. Available from: https://www.who.int/docs/default-source/coronaviruse/global-surveillance-for-covid-v-19-final200321-rev.pdf. Accessed April 29, 2020.
10. SARS | Guidance | Rationale and Goals for Community Containment | CDC [Internet]. 2019. Available from: https://www.cdc.gov/sars/guidance/d-quarantine/rationale.html. Accessed April 29, 2020.
11. Holme P, Masuda N. The Basic Reproduction Number as a Predictor for Epidemic Outbreaks in Temporal Networks. PLoS One. 2015 March 20;10(3); doi:10.1371/journal.pone.0120567.
12. Tellis GJ, Sood A, Sood N. Price of Delay in Covid-19 Lockdowns: Delays Spike Total Cases, Natural Experiments Reveal. Soc Sci Res Network. 2020 May 5; doi:10.2139/ssrn.3592912.
13. Ciliska D, Miccuci S, Dobbins M, Thomas BH. Quality Assessment Tool for Quantitative Studies. Canada: Effective Public Healthcare Panacea Project. Available from: https://www.ephpp.ca/quality-assessment-tool-for-quantitative-studies/. Updated 2010. Accessed May 22, 2020.
14. Dolbeault J, Turinci G. Heterogeneous Social Interactions and The COVID-19 Lockdown Outcome in a Multi-Group SEIR Model. arXiv: 2005.00049 [Preprint]. 2020 [Cited 2020 June 8]. Available from: https://arxiv.org/abs/2005.00049 (2020).
15. Gongalsky MB. Early detection of superspreaders by mass group pool testing can mitigate COVID-19 pandemic. MedRxiv: 10.1101/2020.04.22.20076166v1 [Preprint]. 2020 [Cited 2020 June 8]. Available from: https://doi.org/10.1101/2020.04.22.20076166v1.
16. Hoertel N, Blachier M, Blanco C, Olfson M, Massetti M, Rico MS, et al. Lockdown exit strategies and risk of a second epidemic peak: a stochastic agent-based model of SARS-CoV-2 epidemic in France. MedRxiv: 10.1101/2020.04.30.20086264 [Preprint]. 2020 [Cited 2020 June 8]. Available from: https://doi.org/10.1101/2020.04.30.20086264.
17. Ji T, Chen H-L, Xu J, Wu L-N, Li J-J, Chen K, et al. Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: Early epidemiological findings. Clin Infect Dis. 2020 April 7; doi:10.1093/cid/ciaa390/5816958.
18. Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The Positive Impact of Lockdown in Wuhan on Containing the COVID-19 Outbreak in China. J Travel Med. 2020 March 17;27(3); doi:10.1093/jtm/taaa037.
19. Putra ZA, Abidin SAZ. Application of SEIR Model in COVID-19 and The Effect of Lockdown on Reducing The Number of Active Cases. Indones J Sci Technol. 2020 May 6;5(2):185–92; doi:10.17509/ijost.v5i2.24432.
20. Rao ASRS, Krantz SG. Continued and Serious Lockdown Could Minimize Many Newly Transmitted Cases of COVID-19 in the U.S.: Wavelets, Deterministic Models, and Data. MedRxiv: 10.1101/2020.04.30.20080978 [Preprint]. 2020 [Cited 2020 June 8]. Available from: https://doi.org/10.1101/2020.04.30.20080978.
21. Signorelli C, Scognamiglio T, Odone A. COVID-19 in Italy: Impact of Containment Measures and Prevalence Estimates of Infection in the General Population. Acta Biomed. 2020 April 10; doi:10.23750/abm.v91i3-S.9511
22. Taipale J, Romer P, Linnarsson S. Population-scale testing can suppress the spread of COVID-19. MedRxiv: 10.1101/2020.04.27.20078329v1 [Preprint]. 2020 [Cited 2020 June 8]. Available from: https://doi.org/10.1101/2020.04.27.20078329v1.
23. Tobías A. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up. Sci Total Environ. 2020 April 6;725:138539; doi:10.1016/j.scitotenv.2020.138539.
24. Zhao S, Chen H. Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Quant Biol. 2020 March 11; 1–9; doi:10.1007/s40484-020-0199-0/.
25. Gollier C, Gossner O. Group testing against Covid-19. Covid Economics [Internet]. 2020 April 8 [Accessed 2020 June 8]; 2. Available from: http://eprints.lse.ac.uk/104228/.
26. Wacharapluesadee S, Kaewpom T, Ampoot W, Ghai S, Khamhang W, Worachotsueptrakun K, et al. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19. J Med Virol. 2020 May; doi:10.1002/jmv.26005.
27. Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, Zhang C, Boyle C, Smith M, Phillips JP. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020 May 21; 382:2049-55; doi:10.1056/NEJMsb2005114.
28. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report – 73. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200402-sitrep-73-covid-19.pdf?sfvrsn=5ae25bc7_6#:~:text=The%20incubation%20period%20for%20COVID,persons%20can%20be%20contagious. Published 2020 April 2. Accessed June 16, 2020.
29. Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK, Forrest S, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife. 2020;9:e58728 [Cited 2020 June 16]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314537/
30. Mahajan A. An epidemic model SIPHERD and its application for prediction of the spread of COVID-19 infection for India and USA. ArXiv: 2005.00921v2 [Preprint]. 2020 [Cited 2020 June 16]. Available from: https://doi.org/10.1101/2020.06.25.20139782.
31. Meneghesso G, Garzotto F, Rizzuto R, Vettor R. COVID-19: Effectiveness of Widespread Diagnostic Tests to Prevent Health Care Collapse in the Veneto Region, Italy. Lancet Public Health [Preprint]. 2020 [Cited 2020 June 16]. Available from: https://doi.org/10.2139/ssrn.3576942.
Published
2020-12-18
Info
Issue
Section
Systematic Reviews and Meta-Analysis
Keywords:
COVID-19, SARS-CoV-2 infection, mass screening, lockdown, community containment, quarantine, coronavirus, rapid molecular test
Statistics
  • Abstract views: 207

  • PDF: 61
  • Supplementary: 6
  • HTML: 0
How to Cite
Johanna, N., Citrawijaya, H., & Wangge, G. (2020). Mass screening <em>vs</em> lockdown <em>vs</em&gt; combination of both to control COVID-19: a systematic review. Journal of Public Health Research, 9(4). https://doi.org/10.4081/jphr.2020.2011